如果在讨论实质相同性时我对机密商业信息 (CBI) 有疑虑，该怎么办？

如果在讨论实质相同性时我对机密商业信息 (CBI) 有疑虑，该怎么办？

How do I proceed if I have concerns about confidential business information (CBI) when discussing substance sameness?

考虑在 SIEF 中采取具体措施来保护您认为属于 CBI 但仍需与 SIEF 共享的信息，以便 SIEF 就物质同一性做出结论。例如，您可以：签订保密协议，将文档或其他信息的访问权限限制在特定人员或部门；仅允许在“阅览室”访问某些文件（不允许复印）；同意仅由第三方专家（独立顾问）或受托人审查和/或评估某些文件。您可以通过为有权访问 CBI 文件的人员签订额外的个人保密协议来加强此措施。至少，您应该向其他 SIEF 成员说明该信息确实是 CBI，因此您传达了该信息，并且该信息只能用于根据 REACH 验证物质身份的目的。有关 CBI 的更多信息，请参阅《数据共享指南》第 9 节。

Consider taking specific measures in the SIEF to protect information that you consider CBI, but you nevertheless need to share with the SIEF to conclude on the substance sameness. You can, for example: Have confidentiality agreements that limit access to documents or other information to specific named persons, or departments; and Allow access to certain documents in a ‘reading room’ only (where copying is not allowed); and Agree to have certain documents reviewed and/or assessed only by a third party expert (independent consultant) or a trustee. You can strengthen this by having additional personal confidentiality agreements for those who get access to the CBI documents.  As a minimum, you should specify to the other SIEF members that the information is indeed CBI and, therefore, you communicate it and it can be used only for purposes of the verification of substance identity under REACH. For more information on CBI, see the Guidance on Data-sharing, section 9.